SGLT2 vs GLP1 for Cardiovascular Prevention
Annals On Call Podcast · American College of Physicians
December 20, 202123m 5s
Audio is streamed directly from the publisher (media.acponline.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.